Background {#Sec1}
==========

Primary aldosteronism (PA) is considered the most common cause of endocrine hypertension \[[@CR1], [@CR2]\]; it occurs in approximately 10--20% of hypertensive patients. Adrenocortical adenomas (ACAs) can lead to the autonomous secretion of aldosterone responsible for PA \[[@CR3]\], which is the most frequent form of secondary arterial hypertension \[[@CR4], [@CR5]\]. Even though previous proteomic studies have already focused on differentially expressed proteins (DEPs) and made adequate progress in the understanding of the genetic bases of aldosterone- and cortisol-producing ACAs in the past few years \[[@CR6]--[@CR8]\], the authentic molecular mechanism and fundamental biological activities of DEPs underlying ACA remain ambiguous.

Additionally, quantitative proteomics, as an important methodology based on mass spectrometry, is widely used in the biological and clinical research of various diseases, such as the monitoring of specific disease biomarkers or the identification of functional modules and pathways \[[@CR9]--[@CR12]\]. Bioinformatic analysis of the dynamic transcriptome and expression regulation may guide future research on the mechanisms of ACA. Both isobaric tags for relative and absolute quantitation (iTRAQ) and label-free methods have been broadly applied for quantitative proteomics \[[@CR13]--[@CR16]\]. These techniques are compatible with high-throughput and high speed and can improve the reproducibility of prefractionation of complex peptide mixtures \[[@CR17]--[@CR19]\]. Nevertheless, proteomic studies about ACA are limited. Establishing differentially expressed protein--protein interaction (PPI) networks using bioinformatic data will lead to an improved understanding of the pathogenesis of ACA.

In this work, iTRAQ-based proteomic analysis was conducted based on the etiological study of adrenal adenoma to screen DEPs and explore the relevant mechanisms of its occurrence and development. Results of this study may be used to determine therapeutic targets of clinical significance, which might lay a theoretical foundation for the early diagnosis and effective treatment of adrenal adenoma.

Results {#Sec2}
=======

In this study, iTRAQ was used to assess proteome changes between adrenocortical adenoma tissue and adjacent normal adrenal cortex tissue. On the basis of data acquisition, 753 DEPs were identified: 347 upregulated and 9406 downregulated proteins.

Gene ontology (GO) analysis results {#Sec3}
-----------------------------------

GO is a standardized functional classification system that provides a dynamically updated standardized vocabulary to describe the properties of genes and gene products in an organism from three perspectives: biological process, molecular function, and cell component \[[@CR20]\] (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Gene Ontology (GO) analysis of differentially expressed proteins in adrenocortical adenomas compared with control. GO analysis was performed according three terms: Molecular Functions, Biological Process and Cellular Component Fig. 2GO enrichment analysis (Difference set: target protein set; Reference set: background protein set)

The GO annotation of target proteins can classify these involved proteins in terms of biological process, molecular function, and cellular component (Fig. [2](#Fig2){ref-type="fig"}). Although the proportion of each classification can reflect the impact of biological factors on each classification in the experimental design to a certain extent, evaluations on the significance of each classification depending on the ratio alone are inaccurate. Notably, the distributions of each classification should be considered in overall protein collection, such as all qualitative proteins in an experiment or all known proteins of the species.

Among the 753 DEPs, 347 and 406 proteins were significantly upregulated and downregulated in ACA samples, respectively. The top 16 upregulated proteins included E2F3 protein (Table [1](#Tab1){ref-type="table"}). Of the 16 proteins, keratin was the most upregulated protein, and its level was increased by 3.39-fold in ACA samples. Conversely, 406 proteins were significantly downregulated in ACA samples, and the top 16 downregulated proteins are listed in Table [2](#Tab2){ref-type="table"}. Fig. 3KEGG pathway functional analysis (The numbers represent the ID of proteins in the KEGG pathway, and the green numbers indicate the ID of differentially expressed proteins) Table 1Top 16 increased expressed proteins in adrenal adenoma compared with normal tissueAccessionGene NameDescriptionA/B*P* valueP04259KRT6BKeratin, type II cytoskeletal 6B3.393413.45E-24P08263GSTA1Glutathione S-transferase A13.291194.50E-23Q499G5E2F3E2F3 protein2.932484.08E-19Q05315CLCGalectin-102.858972.68E-18P61927RPL3760S ribosomal protein L372.855842.90E-18P08779KRT16Keratin, type I cytoskeletal 162.812798.77E-18P04196HRGHistidine-rich glycoprotein2.740855.56E-17A0A0E3DDZ3HLA-DPB1MHC class II antigen2.66543.87E-16Q8NFP4MDGA1MAM domain-containing glycosylphosphatidylinositol anchor protein 12.348991.30E-12P02741CRPC-reactive protein2.256591.37E-11Q16772GSTA3Glutathione S-transferase A32.207954.70E-11B2R920cDNA, FLJ941702.114874.88E-10F8TVR8HLA-DRB1MHC class II antigen2.113855.01E-10A7DWG6HLA-DRB1MHC class II antigen2.055562.14E-09Q3T906GNPTABN-acetylglucosamine-1-phosphotransferase subunits alpha/beta2.032063.83E-09A0A024RB62METTL1tRNA (guanine-N(7)-)-methyltransferase2.023474.73E-09 Fig. 4KEGG pathway enrichment analysis (Difference set: target protein set; Reference set: background protein set) Table 2Top 16 decreased expressed proteins in adrenal adenoma compared with normal tissueAccessionGene NameDescriptionA/B*P* valueQ9Y639NPTNNeuroplastin0.7895650.0499304I7GW38ND3NADH-ubiquinone oxidoreductase chain 30.7895220.0498772Q9H993ARMT1Protein-glutamate O-methyltransferase0.7891510.0494224Q8TDY4ASAP3Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 30.7889180.049138Q9NRG7SDR39U1Epimerase family protein SDR39U10.7888990.0491147Q16851UGP2UTP\--glucose-1-phosphate uridylyltransferase0.788880.0490915Q6UX07DHRS13Dehydrogenase/reductase SDR family member 130.7888150.0490121Q02978SLC25A11Mitochondrial 2-oxoglutarate/ malate carrier protein0.7883820.0484886A0A024QZ64ALDOCFructose-bisphosphate aldolase0.7880570.048099H3BQQ1CMC2COX assembly mitochondrial protein 2 homolog0.7878790.0478859P34949MPIMannose-6-phosphate isomerase0.7878260.047823P22748CA4Carbonic anhydrase 40.7876820.0476521Q9BTX3TMEM208Transmembrane protein 2080.7875790.0475292A0A0S2Z5N0BEND5BEN domain containing 5 isoform 10.7872550.0471465F2YHL7APOBEC3FApolipoprotein B mRNA editing enzyme cytidine deaminase0.7872150.0471Q49B96COX19Cytochrome c oxidase assembly protein COX190.7867040.0465007

KEGG pathway analysis {#Sec4}
---------------------

To obtain functional pathway information, we further analyzed the DEPs using the KEGG database. KEGG pathway analysis identified the signaling pathways of DEPs (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}).

PPI network of three DEPs {#Sec5}
-------------------------

The interaction network of three DEPs between ACA samples and adjacent normal adrenal gland tissue was predicted using the String database (Fig. [5](#Fig5){ref-type="fig"}). Fig. 5Protein-protein interaction (PPI) network based on the DEPs-. The round nodes indicate individual proteins. Regulations of protein abundance are shown as red (up-regulation) or green (down-regulation) circles. **a** PPI network based on the up-regulated DEP- E2F3. **b** PPI network based on the down-regulated DEP- KRT6A. **c** PPI network based on the up-regulated DEP- ALDH1A2

Verification of three DEPs by Western blot {#Sec6}
------------------------------------------

We then validated the expression of E2F3, KRT6A, and ALDH1A2 in the abovementioned 24 ACA samples. Western blot analysis revealed that E2F3 and KRT6A expression increased in ACA samples compared with that in adjacent normal adrenal gland tissue (Fig. [6](#Fig6){ref-type="fig"}). By contrast, ALDH1A2 expression significantly decreased in ACA samples. Fig. 6Representative characteristics of adrenocortical adenomas patients for Western blot validation. E2F3 and KRT6A expression increased in ACA samples compared with that in adjacent normal adrenal gland tissue. By contrast, ALDH1A2 expression significantly decreased in ACA samples

Discussion {#Sec7}
==========

iTRAQ is one of the most advanced technology in modern quantitative proteomics \[[@CR21], [@CR22]\]; it combines stable isotope labeling with tandem mass spectrometry \[[@CR23]--[@CR25]\] to compare the relative amount of proteins from normal and diseased samples in a single experiment. Wang WS et al. \[[@CR26]\] revealed that myoferlin is a novel prognostic predictor in pancreatic adenocarcinoma through iTRAQ-based quantitative proteomics. In the present study, we used this method to detect protein expression changes in ACAs to identify DEPs that are critical for the molecular mechanism. In particular, we conducted GO and pathway analyses to explore the role of upregulated proteins in ACA progression. Selected DEPs (E2F3, KRT6A, and ALDH1A2) were validated by Western blot. This work will provide a valuable basis for further studies in the field of transformative medicine.

Transcription factor E2F3 is mainly involved in cell proliferation. It participates in transcription repression in quiescent cells by interacting with histone deacetylase and primarily controls genes regulating S phase entry and DNA synthesis. Some studies predicted that E2F3 transcription factor might be a promising biomarker in various cancer and metabolism diseases \[[@CR27]--[@CR29]\]. For instance, to predict overall survival and cause-specific survival in prostate cancer, E2F3 is considered a relatively independent factor \[[@CR30]\]. Furthermore, E2F3a stimulates the proliferation of ovarian cancer cells through EGFR-driven mitogenic cell signals \[[@CR31]\]. In lung cancer cells, miR-200b can target E2F3 to lessen cell sensitivity to docetaxel \[[@CR32]\]. Martinez et al. \[[@CR33]\] revealed that E2F3 is involved in DNA damage-induced apoptosis and can regulate the DNA damage response. Thus, E2F3 is a multifunctional factor that is worth further investigations.

Epidermis-specific type I keratin is generally involved in the activation of follicular keratinocytes after wounding, but it does not play a major role in keratinocyte proliferation or migration. Keratin 6A also participates in the regulation of epithelial migration by inhibiting the activity of SRC during wound repair \[[@CR34]\]. Chan JKL et al. \[[@CR35]\] verified that manipulating K6a phosphorylation or UPS activity may provide opportunities to harness the innate immunity of epithelia against infection. ALDH1A2 as substrates can recognize free retinal and cellular retinol-binding protein-bound retinal. It mainly metabolizes octanal and decanal but does not metabolize citral, benzaldehyde, acetaldehyde, and propanal efficiently \[[@CR36], [@CR37]\]. Shou S et al. \[[@CR38]\] revealed that defects in IPCD and digit separation in Hoxa13 mutant mice may be partly caused by reduced levels of RA signaling stemming from a loss in the direct regulation of Aldh1a2.

Besides the proteins we mentioned above, some other studies \[[@CR39], [@CR40]\] have revealed that immunohistochemistry detecting CYP11B1 and B2 expression was very promising for patients with primary aldosteronism in establishing a final histopathological diagnosis. We also found CYP11B1 in our differentially expressed protein list, but not in the top 16. This might be due to the individual differences. But we can still pay more attention to this procedure, which could be part of the histopathological routine in all operated primary aldosteronism.

In addition, the discrimination of distinct prognosis between ACA and adrenocortical carcinoma (ACC) deserves our close attention. ACA is a curable neuroendocrine tumor that is usually treated via surgery, whereas ACC is a malignant tumor with a low five-year mortality rate and very poor prognosis \[[@CR41], [@CR42]\]. Therefore, future proteomic studies may focus on meaningful markers that allow the differentiation between ACA and ACC \[[@CR6]\]. An improved understanding of the pathophysiology in these tumors may be obtained by reading lists of hundreds of differentially expressed genes and cellular pathways. There are already some relevant proteomic studies about adrenal cortical tumors \[[@CR43], [@CR44]\]. But we still need to go further.

Thus, the PPI network predicted by bioinformatic analysis can provide some useful indications for follow-up scientific research and meaningful clues to explore and detect the binding residues under specific chemical and physical statuses \[[@CR45]--[@CR48]\]. Further improvement is necessary to achieve substantial interactions \[[@CR49]--[@CR51]\]. Developing powerful methods (such as deep neural networks) and obtaining a systematic understanding of the basic mechanisms of PPI require additional time. We hope that the current work will motivate PPI forecasters to conduct further research.

Conclusions {#Sec8}
===========

The iTRAQ technique is a powerful tool for the identification of protein isoforms and comparative proteome studies. In this study, we identified 753 DEPs in ACA tissue compared with the control. Further studies are necessary to understand the functions of the identified proteins (E2F3, KRT6A, and ALDH1A2) in ACAs. A better understanding of the mechanisms underlying the upregulation of these proteins may be important for therapeutic purposes in PA due to ACAs.

Methods {#Sec9}
=======

Clinical specimens of adrenal adenoma tissue collection {#Sec10}
-------------------------------------------------------

The experimental group randomly collected four clinical specimens of human ACAs from June 2015 to December 2018 in the Second Hospital of Jilin University. The age and gender of all included patients were randomly selected. No adjuvant therapy, such as radiotherapy or chemotherapy, was performed before surgery. ACA tissue was confirmed by pathology after operation. Each patient's tissue was obtained within 30 min after surgical resection and divided into two parts. One tissue was immersed in 4% formalin solution, and the other tissue was stored in sterile nitrogen tubes in liquid nitrogen. The control group was selected from normal adrenal cortex tissues adjacent to the tumorwhich appears normal under the microscope and was confirmed by pathologists in our hospital (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). This experimental study was approved by the Ethics Committee of the Second Hospital of Jilin University.

iTRAQ {#Sec11}
-----

The detailed procedure has been described previously \[[@CR52]\]. In brief, the protein samples were precipitated with acetone--TCA and digested by trypsin to generate proteolytic peptides, which were labeled with iTRAQ reagents. The combined peptide mixtures were analyzed by LC-MS/MS for both identification and quantification. Functional enrichment analysis was performed using GO (<http://www.geneontology.org/>) for biological process, cellular component, and molecular function. Pathway enrichment analysis of protein clusters was performed by KEGG mapping ([http://www.genome.jp/kegg/](http://www.genome.jp/kegg/))).

PPI network construction {#Sec12}
------------------------

STRING v10.1 (<http://string-db.org/>) was applied to analyze the PPI of DEPs identified in the current study and to construct PPI networks. The protein interaction information was extracted from the orthologous proteins of clinical human ACA tissues. The active prediction methods, such as database, experiment, and text mining, were enabled \[[@CR53]\].

Western blot {#Sec13}
------------

Proteins extracted from patient samples were separated by 10% SDS--PAGE and then transferred to PVDF membranes (Millipore, Bedford, MA, USA). Membranes were blocked for 1 h in Tris-buffered saline containing Tween (TBST; 20 mM Tris--HCl \[pH 7.6\], 137 mM NaCl, 0.1% Tween-20) and 5% BSA. After incubation with primary antibodies at 4 °C overnight, the membranes were then washed three times with TBST and incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (anti-rabbit or anti-mouse IgG: 1:4000, Sigma, USA) for 2 h at room temperature. Bound antibodies were detected by HRP-conjugated rabbit anti-mouse antibody. Band density was quantified by ImageJ and normalized to GAPDH.

Statistical analysis {#Sec14}
--------------------

Data are given as the mean ± SEM. GraphPad Prism Software (San Diego, CA, USA) was used for statistical analysis. The significance of differences between groups was determined by a non-paired Student's t-test.

Additional file
===============

 {#Sec15}

Additional file 1:**Figure S1.** The representative image of medullar-free normal cortex. (DOC 7087 kb)
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